Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Short-term Investments (2022 - 2026)

Treace Medical Concepts filings provide 4 years of Short-term Investments readings, the most recent being $37.7 million for Q4 2025.

  • On a quarterly basis, Short-term Investments fell 41.46% to $37.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $37.7 million, a 41.46% decrease, with the full-year FY2025 number at $37.7 million, down 41.46% from a year prior.
  • Short-term Investments hit $37.7 million in Q4 2025 for Treace Medical Concepts, down from $49.7 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $141.0 million in Q1 2023 to a low of $37.7 million in Q4 2025.
  • Median Short-term Investments over the past 4 years was $70.7 million (2024), compared with a mean of $83.0 million.
  • Biggest five-year swings in Short-term Investments: soared 78.4% in 2023 and later tumbled 41.64% in 2024.
  • Treace Medical Concepts' Short-term Investments stood at $61.8 million in 2022, then soared by 78.4% to $110.2 million in 2023, then tumbled by 41.64% to $64.3 million in 2024, then plummeted by 41.46% to $37.7 million in 2025.
  • The last three reported values for Short-term Investments were $37.7 million (Q4 2025), $49.7 million (Q3 2025), and $61.2 million (Q2 2025) per Business Quant data.